Medicamentos de actualidad = Drugs of today

• 

  Año 2019, Vol. 55, Número 9. Dedicado a: Septiembre

  • MONOGRAPHS

    • Brexanolone for the treatment of patients with postpartum depression.

      Kathleen E. Morrison, Anthony B. Cole, S.M. Thompson, Tracy L. Bale Bale

      • Resumen

      págs. 537-544

      

    • Glasdegib for the treatment of adult patients with newly diagnosed acute myeloid leukemia or high-grade myelodysplastic syndrome who are elderly or otherwise unfit for standard induction chemotherapy.

      Scott R. Goldsmith, A.R. Lovell, Mark A. Schroeder

      • Resumen

      págs. 545-562

      

    • Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension.

      J.E. Radell, Janet B. Serle

      • Resumen

      págs. 563-574

      

    • Sacituzumab govitecan: antibody–drug conjugate in triple-negative breast cancer and other solid tumors.

      Kathleen M. Fenn, Kevin M. Kalinsky

      • Resumen

      págs. 575-585

      

  • REVIEW

    • The role of IL-17 and IL-17 receptor inhibitors in the management of generalized pustular psoriasis.

      Kerasia Maria Plachouri, Vlassios Chourdakis, Sophia Georgiou

      • Resumen

      págs. 587-593

      

  • NEW PRODUCT INTROS

    • New product intros [bremelanotide acetate (first-in-class), budesonide/glycopyrronium bromide/formoterol fumarate (new combination), darolutamide, entrectinib, erdafitinib (first-in-class), glucagon (intranasal), ixekizumab (new indication), pexidartinib hydrochloride, tapinarof, tree pollen sublingual immunotherapy (SLIT) tablet allergy vaccine, upadacitinib tartrate, volanesorsen].

      págs. 595-600